Search Results - "Bolwell, B.J."

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies by Olsson, R F, Logan, B R, Chaudhury, S, Zhu, X, Akpek, G, Bolwell, B J, Bredeson, C N, Dvorak, C C, Gupta, V, Ho, V T, Lazarus, H M, Marks, D I, Ringdén, O T H, Pasquini, M C, Schriber, J R, Cooke, K R

“…Clinical outcomes after primary graft failure (PGF) remain poor. Here we present a large retrospective analysis ( n =23 272) which investigates means to…”
Get full text

Utility of the Psychosocial Assessment of Candidates for Transplantation (PACT) Scale in Allogeneic BMT by Foster, L.W, McLellan, L.J, Rybicki, L.A, Bolwell, B.J

Get full text

Ethical Reasoning About Patient Eligibility in Allogeneic BMT Based on Psychosocial Criteria by Foster, L.W, McLellan, L.J, Rybicki, L.A, Bolwell, B.J

Get full text

Repeat Readmissions After Allogeneic Hematopoietic Progenitor Cell Transplantation (HPCT) by Hamilton, B.K, Serafino, S, Kalaycio, M, Andresen, S, Pohlman, B, Dean, R, Hill, B.T, Hanna, R, Duong, H, Sweetenham, J.W, Copelan, E.A, Bolwell, B.J, Sobecks, R

Get full text

Risk Factors for the Development of Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Tranplantation (allo-HSCT) by Hamilton, B.K, Bolwell, B.J, Rybicki, L, Kalaycio, M, Tench, S, Hanna, R, Duong, H, Sobecks, R, Pohlman, B, Andresen, S, Copelan, E.A

Get full text

Early Readmission Rates After Autologous and Allogeneic Hematopoietic Progenitor Cell Transplantation (HPCT) by Hamilton, B.K, Serafino, S, Kalaycio, M, Andresen, S, Pohlman, B, Dean, R, Hill, B.T, Hanna, R, Duong, H, Sweetenham, J.W, Copelan, E.A, Bolwell, B.J, Sobecks, R

Get full text

Quality of Life and Psychosocial Functioning After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) from Matched Sibling Compared to Unrelated Donors by Hamilton, B.K, Lazaryan, A, McLellan, L, Rybicki, L, Foster, L, Cooper, M, Dabney, J, Tench, S, Sobecks, R, Duong, H, Kalaycio, M, Bolwell, B.J, Copelan, E.A

Get full text

Second Solid Cancers After Allogeneic Hematopoietic-Cell Transplantation Using Busulfan-Cyclophosphamide Conditioning by Majhail, N.S, Bajorunaite, R, Sobecks, R.M, Wang, Z, Jacobsohn, D.A, Sorror, M.L, Bolwell, B.J, Wingard, J.R, Rizzo, J.D, Socié, G

Get full text

Impact of Chronic GVHD on Late Relapse, Treatment Related Mortality and Survival After Allogeneic Hematopoietic Cell Transplantation for Hematological Malignancies by Boyiadzis, M, Klein, J.P, Arora, M, Weisdorf, D.J, Hassebroek, A, Lee, S.J, Flowers, M.E, Cutler, C.S, Urbano-Ispizua, A, Antin, J.H, Bolwell, B.J, Cahn, J.-Y, Cairo, M.S, Gale, R.P, Herzig, R.H, Isola, L.M, Jacobsohn, D.A, Jagasia, M.H, Klumpp, T.R, Petersdorf, E.W, Wingard, J.R, Horowitz, M.M, Pavletic, S.Z

Get full text

Effects of spleen status on early outcomes after hematopoietic cell transplantation by Akpek, G, Pasquini, M C, Logan, B, Agovi, M-A, Lazarus, H M, Marks, D I, Bornhaeüser, M, Ringdén, O, Maziarz, R T, Gupta, V, Popat, U, Maharaj, D, Bolwell, B J, Rizzo, J D, Ballen, K K, Cooke, K R, McCarthy, P L, Ho, V T

“…To assess the impact of spleen status on engraftment, and early morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT), we analyzed…”
Get full text

Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation by Fu, S, Rybicki, L, Abounader, D, Andresen, S, Bolwell, B J, Dean, R, Gerds, A, Hamilton, B K, Hanna, R, Hill, B T, Jagadeesh, D, Kalaycio, M E, Liu, H D, Pohlman, B, Sobecks, R M, Majhail, N S

“…The relationship of socioeconomic status (SES) with long-term outcomes in allogeneic hematopoietic cell transplantation (HCT) survivors has not been well…”
Get full text

Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients by Loren, A W, Brazauskas, R, Chow, E J, Gilleece, M, Halter, J, Jacobsohn, D A, Joshi, S, Pidala, J, Quinn, G P, Wang, Z, Apperley, J F, Burns, L J, Hale, G A, Hayes-Lattin, B M, Kamble, R, Lazarus, H, McCarthy, P L, Reddy, V, Warwick, A B, Bolwell, B J, Duncan, C, Socie, G, Sorror, M L, Wingard, J R, Majhail, N S

“…Physician practice variation may be a barrier to informing hematopoietic cell transplant (HCT) recipients about fertility preservation (FP) options. We…”
Get full text

Pregnancy After Hematopoietic-Cell Transplantation: A Report From The Late Effects Committee Of The Center For International Blood And Marrow Transplant Research by Loren, A.W, Wang, Z, Chow, E, Jacobsohn, D.A, Gilleece, M, Halter, J, Joshi, S, Sorror, M.L, Bolwell, B.J, Wingard, J, Socié, G, Rizzo, J.D, Majhail, N.S

Get full text

Treatment With Hyper-CVAD Results In Poor Mobilization Of Peripheral Blood Stem Cells In Patients With Mantle Cell Lymphoma by Hill, B.T, Rybicki, L.A, Smith, S, Dean, R, Kalaycio, M, Pohlman, B, Sweetenham, J.W, Tench, S, Sobecks, R, Andresen, S, Copelan, E, Bolwell, B.J

Get full text

Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients by Hamilton, B K, Law, A D, Rybicki, L, Abounader, D, Dabney, J, Dean, R, Duong, H K, Gerds, A T, Hanna, R, Hill, B T, Jagadeesh, D, Kalaycio, M E, Lawrence, C, McLellan, L, Pohlman, B, Sobecks, R M, Bolwell, B J, Majhail, N S

“…Quality of life (QOL) is an important outcome for hematopoietic cell transplantation (HCT) recipients. Whether pre-HCT QOL adds prognostic information to…”
Get full text

Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation by Hamilton, B K, Rybicki, L, Dabney, J, McLellan, L, Haddad, H, Foster, L, Abounader, D, Kalaycio, M, Sobecks, R, Dean, R, Duong, H, Hill, B T, Bolwell, B J, Copelan, E A

“…Hematopoietic cell transplantation (HCT) has become an established standard of care for many older patients with hematologic malignancies. The effect of…”
Get full text

294: Predictors and Impact of Donor T-cell Chimerism in Myeloablative Allogeneic Stem Cell Transplantation by Dean, R.M, Sobecks, R, Rybicki, L, Brown, S, Copelan, E, Kalaycio, M, Pohlman, B, Sweetenham, J, Andresen, S, Bolwell, B.J

Get full text

Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies by BOLWELL, B. J, POHLMAN, B, SWEETENHAM, J. W, RYBICKI, L, SOBECKS, R, DEAN, R, CURTIS, J, ANDRESEN, S, KOO, A, MINEFF, V, KALAYCIO, M

“…The cellular composition of an autologous graft may influence autologous stem cell transplantation (ASCT) outcome. Etoposide (VP) plus filgrastim (G)…”
Get full text

Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia by Mahindra, A, Bolwell, B J, Rybicki, L, Elder, P, Kalaycio, M, Dean, R, Avalos, B, Sobecks, R, Tench, S, Andresen, S, Pohlman, B, Sweetenham, J, Devine, S, Copelan, E

“…The use of etoposide (VP-16) for stem cell mobilization has been reported as a significant risk factor for the development of therapy-related…”
Get full text

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation by Shaughnessy, P J, Bolwell, B J, van Besien, K, Mistrik, M, Grigg, A, Dodds, A, Prince, H M, Durrant, S, Ilhan, O, Parenti, D, Gallo, J, Foss, F, Apperley, J, Zhang, M-J, Horowitz, M M, Abhyankar, S

“…GVHD is partly mediated by host APCs that activate donor T cells. Extracorporeal photopheresis (ECP) can modulate APC function and benefit some patients with…”
Get full text